Telesis Bio, Inc. TBIO
0.01 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.01155 Day range 0.01155
0.0001 52-week range 0.15
- YTD
- -80.00%
- 1 year
- -16.67%
Analyst view
Consensus: buy
Buy
Price target (mean) —
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 8
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -6.58 | -6.58 – -6.58 | -6.66 | +1.2% | 930.00K | -83.3% | 1 |
| Next quarter | -6.41 | -6.41 – -6.41 | -4.14 | -54.8% | 2.20M | -68.5% | 1 |
| Current year | -24.95 | -24.95 – -24.95 | -22.68 | -10.0% | 9.20M | -66.6% | 1 |
| Next year | -18.89 | -18.89 – -18.89 | -24.95 | +24.3% | 9.60M | +4.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 2023 | Keybanc | Downgrade | Overweight | Sector Weight |
| Nov 8, 2022 | Keybanc | Maintained | — | Overweight |
| Mar 27, 2022 | Keybanc | Maintained | — | Overweight |
| Jul 12, 2021 | Keybanc | Initiated | — | Overweight |
| Jul 12, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Jul 12, 2021 | Jefferies | Initiated | — | Buy |